Your search for ezetimibe returned 113 results

Your search for ezetimibe returned 113 results

Sort Results:

Relevant Recent
Drug Monograph

ZETIA

Ezetimibe 10mg; tabs.
Drug Monograph

NEXLIZET

Bempedoic acid 180mg, ezetimibe 10mg; tabs.
Drug Monograph

VYTORIN

Ezetimibe, simvastatin; 10mg/10mg, 10mg/20mg, 10mg/40mg, 10mg/80mg; tabs.
Drug News

For Statin-Intolerant, Adding This Tx May Improve Dyslipidemia

For statin-intolerant patients with dyslipidemia with ischemic heart disease treated with percutaneous coronary intervention, nutraceuticals alone or in combination with ezetimibe improve the lipid profile, according to a study published in the The American Journal of Cardiology.
Drug News

Evolocumab Compared to Ezetimibe in Statin-Intolerant Patients

For patients with muscle symptoms indicative of statin intolerance, evolocumab is associated with a significantly greater reduction in low-density lipoprotein cholesterol (LDL-C) levels compared with ezetimibe, according to a study published online in the Journal of the American Medical Association.
American College of Cardiology 2011

Combined Therapy of Ezetimibe/Simvastatin plus Extended-Release Niacin Helps Hyperlipidemic Patients Reach Lipid Goals

Data presented at ACC.11, the American College of Cardiology's 60th Annual Scientific Session, demonstrated that combination ezetimibe/simvastatin + extended-release niacin (E/S+N) is an effective therapeutic option for reaching lipid goals in patients with hyperlipidemia, specifically as regards target LDL-C, non-HDL-C, and apoB levels.
American College of Cardiology 2013

Ezetimibe Proves Effective in Children with High-Risk Dyslipidemia

Ezetimibe 10mg/day administered in 6-10 years old children with heterozygous familial or non-familial primary hypercholesterolemia provided significant reductions in LDL-C as well as other lipid parameters after 12 weeks of therapy, as presented at ACC.13, the American College of Cardiology's 62nd Annual Scientific Session.